WO2000051554A3 - Regulation de l'aspect de la peau et composition contenant un compose d'analogue de vitamine d3 fluore - Google Patents

Regulation de l'aspect de la peau et composition contenant un compose d'analogue de vitamine d3 fluore Download PDF

Info

Publication number
WO2000051554A3
WO2000051554A3 PCT/US2000/005414 US0005414W WO0051554A3 WO 2000051554 A3 WO2000051554 A3 WO 2000051554A3 US 0005414 W US0005414 W US 0005414W WO 0051554 A3 WO0051554 A3 WO 0051554A3
Authority
WO
WIPO (PCT)
Prior art keywords
composition
analog compound
skin appearance
regulating skin
fluorinated vitamin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2000/005414
Other languages
English (en)
Other versions
WO2000051554A2 (fr
Inventor
Donald Lynn Bissett
Gary H Posner
Jae Kyoo Lee
Qiang Wang
Amy Violet Trejo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Johns Hopkins University
Original Assignee
Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Johns Hopkins University filed Critical Johns Hopkins University
Priority to AU33904/00A priority Critical patent/AU3390400A/en
Publication of WO2000051554A2 publication Critical patent/WO2000051554A2/fr
Publication of WO2000051554A3 publication Critical patent/WO2000051554A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne des compositions topiques de soin de la peau et des procédés d'utilisation associés. Ces compositions contiennent un analogue de vitamine D3 fluoré qui sert à réguler l'état de la peau, notamment à réguler des signes de vieillissement de la peau.
PCT/US2000/005414 1999-03-05 2000-03-01 Regulation de l'aspect de la peau et composition contenant un compose d'analogue de vitamine d3 fluore Ceased WO2000051554A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU33904/00A AU3390400A (en) 1999-03-05 2000-03-01 Regulating skin appearance and composition with a fluorinated vitamin d3 analog compound

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US12304899P 1999-03-05 1999-03-05
US60/123,048 1999-03-05

Publications (2)

Publication Number Publication Date
WO2000051554A2 WO2000051554A2 (fr) 2000-09-08
WO2000051554A3 true WO2000051554A3 (fr) 2001-01-11

Family

ID=22406435

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/005414 Ceased WO2000051554A2 (fr) 1999-03-05 2000-03-01 Regulation de l'aspect de la peau et composition contenant un compose d'analogue de vitamine d3 fluore

Country Status (2)

Country Link
AU (1) AU3390400A (fr)
WO (1) WO2000051554A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939408A (en) * 1996-05-23 1999-08-17 Hoffman-La Roche Inc. Vitamin D3 analogs
US8106094B2 (en) 1998-07-06 2012-01-31 Johnson & Johnson Consumer Companies, Inc. Compositions and methods for treating skin conditions
US8093293B2 (en) 1998-07-06 2012-01-10 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin conditions
US6284802B1 (en) * 1999-04-19 2001-09-04 The Procter & Gamble Company Methods for regulating the condition of mammalian keratinous tissue
JP2002542179A (ja) * 1999-04-19 2002-12-10 ザ、プロクター、エンド、ギャンブル、カンパニー スキンケア活性物質の組合せを含有するスキンケア組成物
WO2000062741A2 (fr) * 1999-04-19 2000-10-26 The Procter & Gamble Company Compositions de soin pour la peau contenant une combinaison de principes actifs de soin pour la peau
US6444647B1 (en) * 1999-04-19 2002-09-03 The Procter & Gamble Company Skin care compositions containing combination of skin care actives
US7309688B2 (en) 2000-10-27 2007-12-18 Johnson & Johnson Consumer Companies Topical anti-cancer compositions and methods of use thereof
US8431550B2 (en) 2000-10-27 2013-04-30 Johnson & Johnson Consumer Companies, Inc. Topical anti-cancer compositions and methods of use thereof
WO2002087700A1 (fr) * 2001-04-26 2002-11-07 The Procter & Gamble Company Methode, necessaire et dispositif de traitement cosmetique d'etats cutanes
WO2004043469A1 (fr) * 2001-11-16 2004-05-27 Klysz Beatrice M Compositions anti-vieillissement pour le soin de la peau et leurs utilisations
WO2007082542A1 (fr) * 2006-01-17 2007-07-26 Astion Pharma A/S Préparations comprenant de l’oxaprozine et un analogue de vitamine d3 et leur emploi dans la fabrication d'un médicament pour le traitement du psoriasis
WO2022245848A2 (fr) * 2021-05-17 2022-11-24 Aleksander Hinek Composition d'acide tannique et de vitamine d et méthodes d'utilisation

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580968A2 (fr) * 1992-05-20 1994-02-02 F. Hoffmann-La Roche Ag Derivés fluorinés de la vitamine D3
EP0654467A2 (fr) * 1993-11-24 1995-05-24 F. Hoffmann-La Roche Ag Analogues de vitamine D3
EP0671387A1 (fr) * 1994-03-11 1995-09-13 F. Hoffmann-La Roche Ag Dérivé fluoré de vitamine D3
EP0808831A2 (fr) * 1996-05-23 1997-11-26 F. Hoffmann-La Roche Ag Dérivés fluorinés de vitamine D3
US5747479A (en) * 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
WO1999062876A1 (fr) * 1998-06-03 1999-12-09 Johns Hopkins University ANALOGUES 24,24-FLUORES DE 1-α,25-DIHYDROXYVITAMINE D¿3?

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0580968A2 (fr) * 1992-05-20 1994-02-02 F. Hoffmann-La Roche Ag Derivés fluorinés de la vitamine D3
EP0654467A2 (fr) * 1993-11-24 1995-05-24 F. Hoffmann-La Roche Ag Analogues de vitamine D3
EP0671387A1 (fr) * 1994-03-11 1995-09-13 F. Hoffmann-La Roche Ag Dérivé fluoré de vitamine D3
US5747479A (en) * 1996-01-03 1998-05-05 Hoffmann-La Roche Inc. Vitamin D3 analogs useful for reversing the photodamage in sun-exposed skin
EP0808831A2 (fr) * 1996-05-23 1997-11-26 F. Hoffmann-La Roche Ag Dérivés fluorinés de vitamine D3
WO1999062876A1 (fr) * 1998-06-03 1999-12-09 Johns Hopkins University ANALOGUES 24,24-FLUORES DE 1-α,25-DIHYDROXYVITAMINE D¿3?

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
POSNER, GARY H. ET AL: "Conceptually New Sulfone Analogues of the Hormone 1.alpha.,25- Dihydroxyvitamin D3: Synthesis and Preliminary Biological Evaluation", J. MED. CHEM. (1999), 42(18), 3425-3435, 1999, XP000938943 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8039026B1 (en) 1997-07-28 2011-10-18 Johnson & Johnson Consumer Companies, Inc Methods for treating skin pigmentation
US6750229B2 (en) 1998-07-06 2004-06-15 Johnson & Johnson Consumer Companies, Inc. Methods for treating skin pigmentation
US7985404B1 (en) 1999-07-27 2011-07-26 Johnson & Johnson Consumer Companies, Inc. Reducing hair growth, hair follicle and hair shaft size and hair pigmentation
US7192615B2 (en) 2001-02-28 2007-03-20 J&J Consumer Companies, Inc. Compositions containing legume products

Also Published As

Publication number Publication date
AU3390400A (en) 2000-09-21
WO2000051554A2 (fr) 2000-09-08

Similar Documents

Publication Publication Date Title
WO2000051554A3 (fr) Regulation de l'aspect de la peau et composition contenant un compose d'analogue de vitamine d3 fluore
WO2003051294A3 (fr) Compositions acaricides et methodes associees
AU7606196A (en) Topical compositions for regulating the oily/shiny appearance of skin
WO2001054654A3 (fr) Diminution de la croissance capillaire
KR20010012902A (ko) 피부 보호 조성물 및 피부 외관의 개선 방법
WO2003059261A3 (fr) Composition cosmetique contenant du dioxyde de carbone
CA2331395A1 (fr) Nouveaux analogues d'acides gras destines au traitement du diabete
TW200611708A (en) Whitening composition containing reduced coenzyme q
AU3227700A (en) Skin sanitizing compositions
WO2003026583A3 (fr) Compositions cosmetiques a base de pullulane formant un film
WO2004103290A3 (fr) Compositions contenant une amidine et un polyol d'alcane
AU2002323946A1 (en) External preparation
WO2005051341A3 (fr) Composition cosmetique topique
WO2005020877A3 (fr) Utilisation de biotine ou d'un derive de biotine pour eclaircir le teint et traiter les taches de vieillesse
AU2003206690A1 (en) Cosmetic or dermatological preparations for preventing damages to skin caused by peroxides
WO2003077856A3 (fr) Compositions de lotion
SI1569724T1 (sl) Formulacije, ki vsebujejo melatonin, dvokrpi ginko in biotin
CA2571796A1 (fr) Compositions cosmetiques et procede a base d'un agent bronzant et d'acide ursolique encapsule dans un liposome
WO2001040177A3 (fr) Esters de vitamine d3 et utilisation de ces ceux-ci
TW200503767A (en) Improved cosmetic composition
AU2003249868A1 (en) Hair treatment compositions containing xanthine and alpha hydroxy acid
WO2003037288A3 (fr) Composition cosmetique mimant le sebum, et utilisations
AU2094200A (en) Cosmetic or medical preparation for topical use
EP1547576A3 (fr) Composition antisudorale et déodorante en bâtonnet
BR0211784A (pt) Método para reduzir o crescimento capilar humano, uso de alfa-difluorometilornitina, e composição cosmética usada para a redução do crescimento capilar humano

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ CZ DE DE DK DK DM EE EE ES FI FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase